Skip to content
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorder

Can You Have hEDS or HSD With a Borderline Beighton Score?

At a Glance

Yes. A Beighton score just below the age-based cutoff does not automatically rule out hEDS or HSD. Clinicians consider past flexibility with the Five-Part Questionnaire, symptoms, untested joints, injuries, and whether full diagnostic criteria are met.

Yes, you can still be diagnosed with hypermobile Ehlers-Danlos syndrome (hEDS) or Hypermobility Spectrum Disorder (HSD) even if your Beighton score is slightly below the age-specific cutoff. A borderline score does not invalidate your symptoms, nor does it rule out clinically important joint instability. The diagnostic criteria are designed to account for the fact that joint flexibility changes over time and can be affected by injuries, natural aging, or disease [1][2].

The Beighton Score Thresholds
The Beighton score measures your current range of motion across nine specific points on your body. Under the 2017 international criteria, the threshold for generalized joint hypermobility depends on your age and pubertal status [3][4]:

  • Pre-pubertal children and adolescents: Score of 6 or higher (Note: an official hEDS diagnosis is typically reserved for those who have reached biological maturity [5][3]).
  • Pubertal men and women up to age 50: Score of 5 or higher.
  • Adults over age 50: Score of 4 or higher.

The “One Point Below” Rule and the 5-Part Questionnaire
If your current Beighton score is exactly one point below your age-specific threshold, the 2017 criteria state that your doctor should assess your historical hypermobility [6].

They do this using the Five-Part Questionnaire (5PQ), which asks you to recall your past flexibility (for example, whether you could touch your hands flat on the floor as a child, or if your kneecap or shoulder has ever dislocated). If your Beighton score is exactly one point below the threshold AND you answer “yes” to at least two of these five questions, your history supports the requirement for generalized joint hypermobility [7].

Important note: This specific pathway only applies if you are exactly one point below the cutoff. It is not a universal rule to convert any low score into a passing score, and it does not by itself diagnose hEDS.

Why a Beighton Score Might Underestimate Your Hypermobility
It is common for people with a convincing history of hypermobility to fall short on the Beighton score during an exam. A low score accurately measures your current mobility in those specific joints, but it may underestimate your overall or historical instability for several reasons:

  • It only tests a few joints: The Beighton score relies heavily on the upper body. It does not measure the stability of the shoulders, hips, ankles, or feet [8][9]. You could have severe, localized instability in your shoulders or hips and still score a zero on the Beighton test [10].
  • Stiffness and pain: Chronic pain, muscle spasms, and tight hamstrings can restrict your movement on the day of the exam. Pain during movement can prevent you from extending a joint to its full capacity, and you should never force a painful stretch just to achieve a point [11][12].
  • Injuries and surgeries: Past traumas, recurrent dislocations, or joint surgeries often lead to scar tissue and stiffness, actively reducing your mobility over time [6].
  • Age: Joints naturally stiffen as we get older, which is why historical hypermobility must be considered [1][2].

What the Score Can and Cannot Tell You
The Beighton score is a screening tool for selected range of motion, not a comprehensive test of joint instability or a severity score. A restricted score should prompt a discussion of your history and untested joints, not an immediate dismissal of your symptoms.

What This Means for hEDS vs. HSD
Meeting the generalized joint hypermobility requirement is only the first step in diagnosing hEDS [13]. To be officially diagnosed, you must also meet Criterion 2 (which requires at least two of three feature groups: systemic manifestations, musculoskeletal complications, or an affected first-degree relative) and Criterion 3 (the strict exclusion of other connective tissue disorders) [14][15]. Note that a family history is not mandatory to be diagnosed with hEDS, as long as you have enough systemic and musculoskeletal features.

If you have symptomatic hypermobility (such as joint instability, chronic pain, or recurrent dislocations) but you do not meet the full criteria for hEDS, your condition may be classified as Hypermobility Spectrum Disorder (HSD) [16][17]. HSD is not simply a “failed” hEDS diagnosis; it is a clinical classification for symptomatic hypermobility that can be generalized, peripheral, localized, or historical [18].

It is crucial to understand that HSD is not a “lesser” or “milder” diagnosis. Research shows that people with HSD often experience symptoms that substantially overlap with hEDS, including joint pain, frequent subluxations (partial dislocations), fatigue, and other multisystem complaints [19][20]. The medical management, pain relief, and physical therapy strategies for HSD are highly individualized but share the same foundational principles as hEDS care [21][22]. Receiving either label should support your access to symptom-focused care.

Common questions in this guide

Can I still have hEDS or HSD if my Beighton score is just below the cutoff?
Yes. If your score is exactly one point below the age-specific cutoff, a clinician can use your past flexibility and the Five-Part Questionnaire; at least two yes answers support the generalized joint hypermobility requirement. This does not by itself establish hEDS, because hEDS also requires other criteria and exclusion of other disorders; symptomatic people who do not meet hEDS criteria may be diagnosed with HSD.
What does a borderline Beighton score actually show?
The Beighton score measures current range of motion at nine selected points. It is a screening measure, not a severity scale or a complete assessment of joint instability. A lower result should lead to review of your history, symptoms, and joints that the score does not test.
Can pain, aging, or an old injury lower my Beighton score?
Yes. Chronic pain, muscle spasms, tight muscles, injuries, surgeries, scar tissue, and natural aging can reduce movement during an examination. You should not force a painful stretch to obtain a Beighton point.
Which joints are not tested by the Beighton score?
The Beighton score does not directly assess the shoulders, hips, ankles, or feet. Instability in one of these areas can be clinically important even when the score is low, so a clinician may need to examine those joints separately.
What is the difference between hEDS and HSD when my score is borderline?
hEDS requires generalized joint hypermobility plus additional feature groups and the exclusion of other connective tissue disorders. HSD describes symptomatic hypermobility when the full hEDS criteria are not met. HSD is a recognized clinical diagnosis, not simply a failed or lesser hEDS diagnosis.
Can HSD symptoms be significant even if I do not meet hEDS criteria?
Yes. People with HSD can have substantial joint pain, partial dislocations, fatigue, and other symptoms that overlap with hEDS. Treatment is individualized and may include symptom management, pain relief, physical therapy, and rehabilitation.

Get notified when new evidence is published on hypermobility syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (22)
  1. 1

    Masterclass: Hypermobility and hypermobility related disorders.

    Simmonds JV

    Musculoskeletal science & practice 2022; (57()):102465 doi:10.1016/j.msksp.2021.102465.

    PMID: 34808594
  2. 2

    Utilization of the 2017 diagnostic criteria for hEDS by the Toronto GoodHope Ehlers-Danlos syndrome clinic: A retrospective review.

    McGillis L, Mittal N, Santa Mina D, et al.

    American journal of medical genetics. Part A 2020; (182(3)):484-492 doi:10.1002/ajmg.a.61459.

    PMID: 31840928
  3. 3

    Pediatric joint hypermobility: a diagnostic framework and narrative review.

    Tofts LJ, Simmonds J, Schwartz SB, et al.

    Orphanet journal of rare diseases 2023; (18(1)):104 doi:10.1186/s13023-023-02717-2.

    PMID: 37143135
  4. 4

    Generalized Joint Hypermobility in Adults: A Systematic Review With Meta-Analysis to Identify Data-Driven Cut-offs Using the Beighton Score.

    Tofts L, Pacey V, Williams CM, et al.

    Arthritis care & research 2026; (78(8)):987-997 doi:10.1002/acr.70017.

    PMID: 41399207
  5. 5

    Recognizing and Effectively Managing Hypermobility-Related Conditions.

    Russek LN, Stott P, Simmonds J

    Physical therapy 2019; (99(9)):1189-1200 doi:10.1093/ptj/pzz078.

    PMID: 31158283
  6. 6

    Localized and historical hypermobile spectrum disorders share self-reported symptoms and comorbidities with hEDS and HSD.

    Fairweather D, Bruno KA, Darakjian AA, et al.

    Frontiers in medicine 2025; (12()):1594796 doi:10.3389/fmed.2025.1594796.

    PMID: 40880755
  7. 7

    Characterizing sexual dysfunction in females with hypermobile Ehlers Danlos syndrome or hypermobility spectrum disorder and genito-pelvic pain through cross-sectional analysis.

    Barton L, Moss C, Ellis C, et al.

    Rheumatology international 2026; (46(7)).

    PMID: 42283871
  8. 8

    The Beighton Score as a measure of generalised joint hypermobility.

    Malek S, Reinhold EJ, Pearce GS

    Rheumatology international 2021; (41(10)):1707-1716 doi:10.1007/s00296-021-04832-4.

    PMID: 33738549
  9. 9

    Lower Limb Biomechanical Observations in Hypermobile Children: An Exploratory Case-Control Study.

    Maarj M, Pacey V, Tofts L, et al.

    International journal of environmental research and public health 2025; (22(12)) doi:10.3390/ijerph22121776.

    PMID: 41464410
  10. 10

    Does the Beighton Score Correlate With Specific Measures of Shoulder Joint Laxity?

    Whitehead NA, Mohammed KD, Fulcher ML

    Orthopaedic journal of sports medicine 2018; (6(5)):2325967118770633 doi:10.1177/2325967118770633.

    PMID: 29770343
  11. 11

    Gleno-humeral abduction measurement in patients with Ehlers-Danlos syndrome.

    Cypel D

    Orthopaedics & traumatology, surgery & research : OTSR 2019; (105(2)):287-290 doi:10.1016/j.otsr.2018.12.007.

    PMID: 30885819
  12. 12

    Self-rated joint hypermobility: the five-part questionnaire evaluated in a Swedish non-clinical adult population.

    Glans M, Humble MB, Elwin M, Bejerot S

    BMC musculoskeletal disorders 2020; (21(1)):174 doi:10.1186/s12891-020-3067-1.

    PMID: 32183749
  13. 13

    Prevalence of hypermobile Ehlers-Danlos syndrome in postural orthostatic tachycardia syndrome.

    Miller AJ, Stiles LE, Sheehan T, et al.

    Autonomic neuroscience : basic & clinical 2020; (224()):102637 doi:10.1016/j.autneu.2020.102637.

    PMID: 31954224
  14. 14

    Hypermobile Ehlers-Danlos Syndrome: Diagnostic Challenges and the Role of Genetic Testing.

    Forghani I, See J, McGonigle WC

    Genes 2025; (16(5)) doi:10.3390/genes16050530.

    PMID: 40428350
  15. 15

    Placing joint hypermobility in context: traits, disorders and syndromes.

    Morlino S, Castori M

    British medical bulletin 2023; (147(1)):90-107 doi:10.1093/bmb/ldad013.

    PMID: 37350130
  16. 16

    Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders.

    Yew KS, Kamps-Schmitt KA, Borge R

    American family physician 2021; (103(8)):481-492.

    PMID: 33856167
  17. 17

    Deconstructing and reconstructing joint hypermobility on an evo-devo perspective.

    Castori M

    Rheumatology (Oxford, England) 2021; (60(6)):2537-2544 doi:10.1093/rheumatology/keab196.

    PMID: 33668066
  18. 18

    Diagnosis and Management of Hypermobility Spectrum Disorders in Primary Care.

    Atwell K, Michael W, Dubey J, et al.

    Journal of the American Board of Family Medicine : JABFM 2021; (34(4)):838-848 doi:10.3122/jabfm.2021.04.200374.

    PMID: 34312277
  19. 19

    Similarities and differences in self-reported symptoms and comorbidities between hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.

    Darakjian AA, Bhutani M, Fairweather D, et al.

    Rheumatology advances in practice 2024; (8(4)):rkae134 doi:10.1093/rap/rkae134.

    PMID: 39660107
  20. 20

    Exploring the underlying mechanism of pain-related disability in hypermobile adolescents with chronic musculoskeletal pain.

    van Meulenbroek T, Huijnen IPJ, Simons LE, et al.

    Scandinavian journal of pain 2021; (21(1)):22-31 doi:10.1515/sjpain-2020-0023.

    PMID: 32862151
  21. 21

    Proximity extension assay-based serum proteomic profiling identifies shared protein signatures in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.

    Cinquina V, Carini G, Chiarelli N, et al.

    Clinical proteomics 2026; (23(1)).

    PMID: 41794655
  22. 22

    Looking back and beyond the 2017 diagnostic criteria for hypermobile Ehlers-Danlos syndrome: A retrospective cross-sectional study from an Italian reference center.

    Ritelli M, Chiarelli N, Cinquina V, et al.

    American journal of medical genetics. Part A 2024; (194(2)):174-194 doi:10.1002/ajmg.a.63426.

    PMID: 37774134

This page explains how a borderline Beighton score may be interpreted in hEDS and HSD for educational purposes only and does not replace medical advice. A qualified clinician should assess your full history, symptoms, and examination.